Abstract
The non-structural protein 1 of influenza virus (NS1) is a relatively small polypeptide with an outstanding number of ascribed functions. NS1 is the main viral antagonist of the innate immune response during influenza virus infection, chiefly by inhibiting the type I interferon system at multiple steps. As such, its role is critical to overcome the first barrier the host presents to halt the viral infection. However, the pro-viral activities of this well-studied protein go far beyond and include regulation of viral RNA and protein synthesis, and disruption of the host cell homeostasis by dramatically affecting general gene expression while tweaking the PI3K signaling network. Because of all of this, NS1 is a key virulence factor that impacts influenza pathogenesis, and adaptation to new hosts, making it an attractive target for control strategies. Here, we will overview the many roles that have been ascribed to the NS1 protein, and give insights into the sequence features and structural properties that make them possible, highlighting the need to understand how NS1 can actually perform all of these functions during viral infection.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Alonso-Caplen FV, Krug RM (1991) Regulation of the extent of splicing of influenza virus NS1 mRNA: role of the rates of splicing and of the nucleocytoplasmic transport of NS1 mRNA. Mol Cell Biol 11:1092–1098
Alonso-Caplen FV, Nemeroff ME, Qiu Y, Krug RM (1992) Nucleocytoplasmic transport: the influenza virus NS1 protein regulates the transport of spliced NS2 mRNA and its precursor NS1 mRNA. Genes Dev 6:255–267
Aragón T, de la Luna S, Novoa I, Carrasco L, Ortin J, Nieto A (2000) Eukaryotic translation initiation factor 4GI is a cellular target for NS1 protein, a translational activator of influenza virus. Mol Cell Biol 20:6259–6268
Aramini JM, Ma LC, Zhou L, Schauder CM, Hamilton K, Amer BR, Mack TR, Lee HW, Ciccosanti CT, Zhao L, Xiao R, Krug RM, Montelione GT (2011) Dimer interface of the effector domain of non-structural protein 1 from influenza A virus: an interface with multiple functions. J Biol Chem 286:26050–26060
Ayllon J, GarcĂa-Sastre A, Hale BG (2012a) Influenza A viruses and PI3K: are there time, place and manner restrictions? Virulence 3:411–414
Ayllon J, Hale BG, GarcĂa-Sastre A (2012b) Strain-specific contribution of NS1-activated phosphoinositide 3-kinase signaling to influenza A virus replication and virulence. J Virol 86:5366–5370
Ayllon J, Russell RJ, GarcĂa-Sastre A, Hale BG (2012c) Contribution of NS1 effector domain dimerization to influenza A virus replication and virulence. J Virol 86:13095–13098
Barabino SM, Hubner W, Jenny A, Minvielle-Sebastia L, Keller W (1997) The 30-kD subunit of mammalian cleavage and polyadenylation specificity factor and its yeast homolog are RNA-binding zinc finger proteins. Genes Dev 11:1703–1716
Baskin CR, Bielefeldt-Ohmann H, Tumpey TM, Sabourin PJ, Long JP, GarcĂa-Sastre A, Tolnay AE, Albrecht R, Pyles JA, Olson PH, Aicher LD, Rosenzweig ER, Murali-Krishna K, Clark EA, Kotur MS, Fornek JL, Proll S, Palermo RE, Sabourin CL, Katze MG (2009) Early and sustained innate immune response defines pathology and death in nonhuman primates infected by highly pathogenic influenza virus. Proc Natl Acad Sci USA 106:3455–3460
Basu D, Walkiewicz MP, Frieman M, Baric RS, Auble DT, Engel DA (2009) Novel influenza virus NS1 antagonists block replication and restore innate immune function. J Virol 83:1881–1891
Bergmann M, GarcĂa-Sastre A, Carnero E, Pehamberger H, Wolff K, Palese P, Muster T (2000) Influenza virus NS1 protein counteracts PKR-mediated inhibition of replication. J Virol 74:6203–6206
Beyleveld G, White KM, Ayllon J, Shaw ML (2013) New-generation screening assays for the detection of anti-influenza compounds targeting viral and host functions. Antiviral Res 100:120–132
Bornholdt ZA, Prasad BV (2006) X-ray structure of influenza virus NS1 effector domain. Nat Struct Mol Biol 13:559–560
Bornholdt ZA, Prasad BV (2008) X-ray structure of NS1 from a highly pathogenic H5N1 influenza virus. Nature 456:985–988
Brown EG, Liu H, Kit LC, Baird S, Nesrallah M (2001) Pattern of mutation in the genome of influenza A virus on adaptation to increased virulence in the mouse lung: identification of functional themes. Proc Natl Acad Sci USA 98:6883–6888
Burgui I, Aragon T, Ortin J, Nieto A (2003) PABP1 and eIF4GI associate with influenza virus NS1 protein in viral mRNA translation initiation complexes. J Gen Virol 84:3263–3274
Carrillo B, Choi JM, Bornholdt ZA, Sankaran B, Rice AP, Prasad BV (2014) The influenza A virus protein NS1 displays structural polymorphism. J Virol 88:4113–4122
Chen G, Liu CH, Zhou L, Krug RM (2014) Cellular DDX21 RNA Helicase inhibits influenza A virus replication but is counteracted by the viral NS1 protein. Cell Host Microbe 15:484–493
Cheng A, Wong SM, Yuan YA (2009) Structural basis for dsRNA recognition by NS1 protein of influenza A virus. Cell Res 19:187–195
Chien CY, Tejero R, Huang Y, Zimmerman DE, Rios CB, Krug RM, Montelione GT (1997) A novel RNA-binding motif in influenza A virus non-structural protein 1. Nat Struct Biol 4:891–895
Chien CY, Xu Y, Xiao R, Aramini JM, Sahasrabudhe PV, Krug RM, Montelione GT (2004) Biophysical characterization of the complex between double-stranded RNA and the N-terminal domain of the NS1 protein from influenza A virus: evidence for a novel RNA-binding mode. Biochemistry 43:1950–1962
Cho EJ, Xia S, Ma LC, Robertus J, Krug RM, Anslyn EV, Montelione GT, Ellington AD (2012) Identification of influenza virus inhibitors targeting NS1A utilizing fluorescence polarization-based high-throughput assay. J Biomol Screen 17:448–459
Colgan DF, Manley JL (1997) Mechanism and regulation of mRNA polyadenylation. Genes Dev 11:2755–2766
Dankar SK, Miranda E, Forbes NE, Pelchat M, Tavassoli A, Selman M, Ping J, Jia J, Brown EG (2013) Influenza A/Hong Kong/156/1997(H5N1) virus NS1 gene mutations F103L and M106I both increase IFN antagonism, virulence and cytoplasmic localization but differ in binding to RIG-I and CPSF30. Virol J 10:243
Darapaneni V, Prabhaker VK, Kukol A (2009) Large-scale analysis of influenza A virus sequences reveals potential drug target sites of non-structural proteins. J Gen Virol 90:2124–2133
Das K, Ma LC, Xiao R, Radvansky B, Aramini J, Zhao L, Marklund J, Kuo RL, Twu KY, Arnold E, Krug RM, Montelione GT (2008) Structural basis for suppression of a host antiviral response by influenza A virus. Proc Natl Acad Sci USA 105:13093–13098
Dauber B, Heins G, Wolff T (2004) The influenza B virus nonstructural NS1 protein is essential for efficient viral growth and antagonizes beta interferon induction. J Virol 78:1865–1872
Dauber B, Schneider J, Wolff T (2006) Double-stranded RNA binding of influenza B virus nonstructural NS1 protein inhibits protein kinase R but is not essential to antagonize production of alpha/beta interferon. J Virol 80:11667–11677
de Chassey B, Aublin-Gex A, Ruggieri A, Meyniel-Schicklin L, Pradezynski F, Davoust N, Chantier T, Tafforeau L, Mangeot PE, Ciancia C, Perrin-Cocon L, Bartenschlager R, Andre P, Lotteau V (2013) The interactomes of influenza virus NS1 and NS2 proteins identify new host factors and provide insights for ADAR1 playing a supportive role in virus replication. PLoS Pathog 9:e1003440
Donelan NR, Dauber B, Wang X, Basler CF, Wolff T, GarcĂa-Sastre A (2004) The N- and C-terminal domains of the NS1 protein of influenza B virus can independently inhibit IRF-3 and beta interferon promoter activation. J Virol 78:11574–11582
Dundon WG, Capua I (2009) A closer look at the NS1 of influenza virus. Viruses 1:1057–1072
Egorov A, Brandt S, Sereinig S, Romanova J, Ferko B, Katinger D, Grassauer A, Alexandrova G, Katinger H, Muster T (1998) Transfectant influenza A viruses with long deletions in the NS1 protein grow efficiently in vero cells. J Virol 72:6437–6441
Ehrhardt C, Ludwig S (2009) A new player in a deadly game: influenza viruses and the PI3K/Akt signalling pathway. Cell Microbiol 11:863–871
Ehrhardt C, Marjuki H, Wolff T, Nurnberg B, Planz O, Pleschka S, Ludwig S (2006) Bivalent role of the phosphatidylinositol-3-kinase (PI3K) during influenza virus infection and host cell defence. Cell Microbiol 8:1336–1348
Ehrhardt C, Wolff T, Ludwig S (2007) Activation of phosphatidylinositol 3-kinase signaling by the nonstructural NS1 protein is not conserved among type A and B influenza viruses. J Virol 81:12097–12100
Engel DA (2013) The influenza virus NS1 protein as a therapeutic target. Antiviral Res 99:409–416
Engelman JA, Luo J, Cantley LC (2006) The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism. Nat Rev Genet 7:606–619
Everett RD, Boutell C, Hale BG (2013) Interplay between viruses and host sumoylation pathways. Nat Rev Microbiol 11:400–411
Falcon AM, Fortes P, Marion RM, Beloso A, Ortin J (1999) Interaction of influenza virus NS1 protein and the human homologue of Staufen in vivo and in vitro. Nucleic Acids Res 27:2241–2247
Fortes P, Beloso A, Ortin J (1994) Influenza virus NS1 protein inhibits pre-mRNA splicing and blocks mRNA nucleocytoplasmic transport. EMBO J 13:704–712
Gack MU, Albrecht RA, Urano T, Inn KS, Huang IC, Carnero E, Farzan M, Inoue S, Jung JU, GarcĂa-Sastre A (2009) Influenza A virus NS1 targets the ubiquitin ligase TRIM25 to evade recognition by the host viral RNA sensor RIG-I. Cell Host Microbe 5:439–449
Gack MU, Shin YC, Joo CH, Urano T, Liang C, Sun L, Takeuchi O, Akira S, Chen Z, Inoue S, Jung JU (2007) TRIM25 RING-finger E3 ubiquitin ligase is essential for RIG-I-mediated antiviral activity. Nature 446:916–920
Gallacher M, Brown SG, Hale BG, Fearns R, Olver RE, Randall RE, Wilson SM (2009) Cation currents in human airway epithelial cells induced by infection with influenza A virus. J Physiol 587:3159–3173
GarcĂa MA, Gil J, Ventoso I, Guerra S, Domingo E, Rivas C, Esteban M (2006) Impact of protein kinase PKR in cell biology: from antiviral to antiproliferative action. Microbiol Mol Biol Rev 70:1032–1060
GarcĂa-Sastre A (2011) Induction and evasion of type I interferon responses by influenza viruses. Virus Res 162:12–18
GarcĂa-Sastre A, Egorov A, Matassov D, Brandt S, Levy DE, Durbin JE, Palese P, Muster T (1998) Influenza A virus lacking the NS1 gene replicates in interferon-deficient systems. Virology 252:324–330
Garfinkel MS, Katze MG (1993) Translational control by influenza virus. Selective translation is mediated by sequences within the viral mRNA 5′-untranslated region. J Biol Chem 268:22223–22226
Golebiewski L, Liu H, Javier RT, Rice AP (2011) The avian influenza virus NS1 ESEV PDZ binding motif associates with Dlg1 and Scribble to disrupt cellular tight junctions. J Virol 85:10639–10648
Goodman AG, Smith JA, Balachandran S, Perwitasari O, Proll SC, Thomas MJ, Korth MJ, Barber GN, Schiff LA, Katze MG (2007) The cellular protein P58IPK regulates influenza virus mRNA translation and replication through a PKR-mediated mechanism. J Virol 81:2221–2230
Graef KM, Vreede FT, Lau YF, McCall AW, Carr SM, Subbarao K, Fodor E (2010) The PB2 subunit of the influenza virus RNA polymerase affects virulence by interacting with the mitochondrial antiviral signaling protein and inhibiting expression of beta interferon. J Virol 84:8433–8445
Greenspan D, Palese P, Krystal M (1988) Two nuclear location signals in the influenza virus NS1 nonstructural protein. J Virol 62:3020–3026
Grimm D, Staeheli P, Hufbauer M, Koerner I, Martinez-Sobrido L, Solorzano A, GarcĂa-Sastre A, Haller O, Kochs G (2007) Replication fitness determines high virulence of influenza A virus in mice carrying functional Mx1 resistance gene. Proc Natl Acad Sci USA 104:6806–6811
Guan R, Ma LC, Leonard PG, Amer BR, Sridharan H, Zhao C, Krug RM, Montelione GT (2011) Structural basis for the sequence-specific recognition of human ISG15 by the NS1 protein of influenza B virus. Proc Natl Acad Sci USA 108:13468–13473
Guerra S, Caceres A, Knobeloch KP, Horak I, Esteban M (2008) Vaccinia virus E3 protein prevents the antiviral action of ISG15. PLoS Pathog 4:e1000096
Guo Z, Chen LM, Zeng H, Gomez JA, Plowden J, Fujita T, Katz JM, Donis RO, Sambhara S (2007) NS1 protein of influenza A virus inhibits the function of intracytoplasmic pathogen sensor, RIG-I. Am J Respir Cell Mol Biol 36:263–269
Hai R, Martinez-Sobrido L, Fraser KA, Ayllon J, GarcĂa-Sastre A, Palese P (2008) Influenza B virus NS1-truncated mutants: live-attenuated vaccine approach. J Virol 82:10580–10590
Hale BG, Barclay WS, Randall RE, Russell RJ (2008a) Structure of an avian influenza A virus NS1 protein effector domain. Virology 378:1–5
Hale BG, Batty IH, Downes CP, Randall RE (2008b) Binding of influenza A virus NS1 protein to the inter-SH2 domain of p85 suggests a novel mechanism for phosphoinositide 3-kinase activation. J Biol Chem 283:1372–1380
Hale BG, Randall RE, Ortin J, Jackson D (2008c) The multifunctional NS1 protein of influenza A viruses. J Gen Virol 89:2359–2376
Hale BG, Jackson D, Chen YH, Lamb RA, Randall RE (2006) Influenza A virus NS1 protein binds p85beta and activates phosphatidylinositol-3-kinase signaling. Proc Natl Acad Sci USA 103:14194–14199
Hale BG, Kerry PS, Jackson D, Precious BL, Gray A, Killip MJ, Randall RE, Russell RJ (2010a) Structural insights into phosphoinositide 3-kinase activation by the influenza A virus NS1 protein. Proc Natl Acad Sci USA 107:1954–1959
Hale BG, Steel J, Medina RA, Manicassamy B, Ye J, Hickman D, Hai R, Schmolke M, Lowen AC, Perez DR, GarcĂa-Sastre A (2010b) Inefficient control of host gene expression by the 2009 pandemic H1N1 influenza A virus NS1 protein. J Virol 84:6909–6922
Hale BG, Knebel A, Botting CH, Galloway CS, Precious BL, Jackson D, Elliott RM, Randall RE (2009) CDK/ERK-mediated phosphorylation of the human influenza A virus NS1 protein at threonine-215. Virology 383:6–11
Hatada E, Fukuda R (1992) Binding of influenza A virus NS1 protein to dsRNA in vitro. J Gen Virol 73(Pt 12):3325–3329
Hatada E, Takizawa T, Fukuda R (1992) Specific binding of influenza A virus NS1 protein to the virus minus-sense RNA in vitro. J Gen Virol 73(Pt 1):17–25
Hayman A, Comely S, Lackenby A, Murphy S, McCauley J, Goodbourn S, Barclay W (2006) Variation in the ability of human influenza A viruses to induce and inhibit the IFN-beta pathway. Virology 347:52–64
Horisberger MA, Staeheli P, Haller O (1983) Interferon induces a unique protein in mouse cells bearing a gene for resistance to influenza virus. Proc Natl Acad Sci USA 80:1910–1914
Hossain MJ, Hickman D, Perez DR (2008) Evidence of expanded host range and mammalian-associated genetic changes in a duck H9N2 influenza virus following adaptation in quail and chickens. PLoS One 3:e3170
Hovanessian AG (1989) The double stranded RNA-activated protein kinase induced by interferon: dsRNA-PK. J Interferon Res 9:641–647
Hrincius ER, Hennecke AK, Gensler L, Nordhoff C, Anhlan D, Vogel P, McCullers JA, Ludwig S, Ehrhardt C (2012) A single point mutation (Y89F) within the non-structural protein 1 of influenza A viruses limits epithelial cell tropism and virulence in mice. Am J Pathol 180:2361–2374
Hsiang TY, Zhou L, Krug RM (2012) Roles of the phosphorylation of specific serines and threonines in the NS1 protein of human influenza A viruses. J Virol 86:10370–10376
Huang TS, Palese P, Krystal M (1990) Determination of influenza virus proteins required for genome replication. J Virol 64:5669–5673
Inglis SC, Barrett T, Brown CM, Almond JW (1979) The smallest genome RNA segment of influenza virus contains two genes that may overlap. Proc Natl Acad Sci USA 76:3790–3794
Isaacs A, Lindenmann J (1957) Virus interference. I. The interferon. Proc R Soc Lond B Biol Sci 147:258–267
Iwai A, Shiozaki T, Kawai T, Akira S, Kawaoka Y, Takada A, Kida H, Miyazaki T (2010) Influenza A virus polymerase inhibits type I interferon induction by binding to interferon beta promoter stimulator 1. J Biol Chem 285:32064–32074
Iwasaki A, Medzhitov R (2010) Regulation of adaptive immunity by the innate immune system. Science 327:291–295
Jablonski JJ, Basu D, Engel DA, Geysen HM (2012) Design, synthesis, and evaluation of novel small molecule inhibitors of the influenza virus protein NS1. Bioorg Med Chem 20:487–497
Jackson D, Hossain MJ, Hickman D, Perez DR, Lamb RA (2008) A new influenza virus virulence determinant: the NS1 protein four C-terminal residues modulate pathogenicity. Proc Natl Acad Sci USA 105:4381–4386
Jackson D, Killip MJ, Galloway CS, Russell RJ, Randall RE (2010) Loss of function of the influenza A virus NS1 protein promotes apoptosis but this is not due to a failure to activate phosphatidylinositol 3-kinase (PI3K). Virology 396:94–105
Javier RT, Rice AP (2011) Emerging theme: cellular PDZ proteins as common targets of pathogenic viruses. J Virol 85:11544–11556
Katze MG, Detjen BM, Safer B, Krug RM (1986) Translational control by influenza virus: suppression of the kinase that phosphorylates the alpha subunit of initiation factor eIF-2 and selective translation of influenza viral mRNAs. Mol Cell Biol 6:1741–1750
Katze MG, Tomita J, Black T, Krug RM, Safer B, Hovanessian A (1988) Influenza virus regulates protein synthesis during infection by repressing autophosphorylation and activity of the cellular 68,000-Mr protein kinase. J Virol 62:3710–3717
Kerry PS, Ayllon J, Taylor MA, Hass C, Lewis A, GarcĂa-Sastre A, Randall RE, Hale BG, Russell RJ (2011) A transient homotypic interaction model for the influenza A virus NS1 protein effector domain. PLoS One 6:e17946
Kochs G, GarcĂa-Sastre A, Martinez-Sobrido L (2007) Multiple anti-interferon actions of the influenza A virus NS1 protein. J Virol 81:7011–7021
Koennecke I, Boschek CB, Scholtissek C (1981) Isolation and properties of a temperature-sensitive mutant (ts 412) of an influenza A virus recombinant with a ts lesion in the gene coding for the nonstructural protein. Virology 110:16–25
Kok K, Geering B, Vanhaesebroeck B (2009) Regulation of phosphoinositide 3-kinase expression in health and disease. Trends Biochem Sci 34:115–127
Krug RM, Aramini JM (2009) Emerging antiviral targets for influenza A virus. Trends Pharmacol Sci 30:269–277
Krug RM, Etkind PR (1973) Cytoplasmic and nuclear virus-specific proteins in influenza virus-infected MDCK cells. Virology 56:334–348
Kuo RL, Krug RM (2009) Influenza a virus polymerase is an integral component of the CPSF30-NS1A protein complex in infected cells. J Virol 83:1611–1616
Kuo RL, Zhao C, Malur M, Krug RM (2010) Influenza A virus strains that circulate in humans differ in the ability of their NS1 proteins to block the activation of IRF3 and interferon-beta transcription. Virology 408:146–158
Lai C, Struckhoff JJ, Schneider J, Martinez-Sobrido L, Wolff T, GarcĂa-Sastre A, Zhang DE, Lenschow DJ (2009) Mice lacking the ISG15 E1 enzyme UbE1L demonstrate increased susceptibility to both mouse-adapted and non-mouse-adapted influenza B virus infection. J Virol 83:1147–1151
Lamb RA, Choppin PW (1979) Segment 8 of the influenza virus genome is unique in coding for two polypeptides. Proc Natl Acad Sci USA 76:4908–4912
Lamb RA, Lai CJ (1980) Sequence of interrupted and uninterrupted mRNAs and cloned DNA coding for the two overlapping nonstructural proteins of influenza virus. Cell 21:475–485
Lazarowitz SG, Compans RW, Choppin PW (1971) Influenza virus structural and nonstructural proteins in infected cells and their plasma membranes. Virology 46:830–843
Li S, Min JY, Krug RM, Sen GC (2006) Binding of the influenza A virus NS1 protein to PKR mediates the inhibition of its activation by either PACT or double-stranded RNA. Virology 349:13–21
Li Y, Chen ZY, Wang W, Baker CC, Krug RM (2001) The 3′-end-processing factor CPSF is required for the splicing of single-intron pre-mRNAs in vivo. RNA 7:920–931
Li Y, Yamakita Y, Krug RM (1998) Regulation of a nuclear export signal by an adjacent inhibitory sequence: the effector domain of the influenza virus NS1 protein. Proc Natl Acad Sci USA 95:4864–4869
Lindenmann J (1960) Interferon and inverse interference. Z Haut Geschlechtskr 146:287–309
Lindenmann J (1962) Resistance of mice to mouse-adapted influenza A virus. Virology 16:203–204
Liu J, Lynch PA, Chien CY, Montelione GT, Krug RM, Berman HM (1997) Crystal structure of the unique RNA-binding domain of the influenza virus NS1 protein. Nat Struct Biol 4:896–899
Liu H, Golebiewski L, Dow EC, Krug RM, Javier RT, Rice AP (2010) The ESEV PDZ-binding motif of the avian influenza A virus NS1 protein protects infected cells from apoptosis by directly targeting Scribble. J Virol 84:11164–11174
Lu Y, Wambach M, Katze MG, Krug RM (1995) Binding of the influenza virus NS1 protein to double-stranded RNA inhibits the activation of the protein kinase that phosphorylates the elF-2 translation initiation factor. Virology 214:222–228
Ludwig S, Schultz U, Mandler J, Fitch WM, Scholtissek C (1991) Phylogenetic relationship of the nonstructural (NS) genes of influenza A viruses. Virology 183:566–577
Ludwig S, Wang X, Ehrhardt C, Zheng H, Donelan N, Planz O, Pleschka S, GarcĂa-Sastre A, Heins G, Wolff T (2002) The influenza A virus NS1 protein inhibits activation of Jun N-terminal kinase and AP-1 transcription factors. J Virol 76:11166–11171
Maamary J, Pica N, Belicha-Villanueva A, Chou YY, Krammer F, Gao Q, GarcĂa-Sastre A, Palese P (2012) Attenuated influenza virus construct with enhanced hemagglutinin protein expression. J Virol 86:5782–5790
Manicassamy B, Manicassamy S, Belicha-Villanueva A, Pisanelli G, Pulendran B, GarcĂa-Sastre A (2010) Analysis of in vivo dynamics of influenza virus infection in mice using a GFP reporter virus. Proc Natl Acad Sci USA 107:11531–11536
Marazzi I, Ho JS, Kim J, Manicassamy B, Dewell S, Albrecht RA, Seibert CW, Schaefer U, Jeffrey KL, Prinjha RK, Lee K, GarcĂa-Sastre A, Roeder RG, Tarakhovsky A (2012) Suppression of the antiviral response by an influenza histone mimic. Nature 483:428–433
Marion RM, Aragon T, Beloso A, Nieto A, Ortin J (1997a) The N-terminal half of the influenza virus NS1 protein is sufficient for nuclear retention of mRNA and enhancement of viral mRNA translation. Nucleic Acids Res 25:4271–4277
Marion RM, Zurcher T, de la Luna S, Ortin J (1997b) Influenza virus NS1 protein interacts with viral transcription-replication complexes in vivo. J Gen Virol 78(Pt 10):2447–2451
Maroto M, Fernandez Y, Ortin J, Pelaez F, Cabello MA (2008) Development of an HTS assay for the search of anti-influenza agents targeting the interaction of viral RNA with the NS1 protein. J Biomol Screen 13:581–590
Mata MA, Satterly N, Versteeg GA, Frantz D, Wei S, Williams N, Schmolke M, Pena-Llopis S, Brugarolas J, Forst CV, White MA, GarcĂa-Sastre A, Roth MG, Fontoura BM (2011) Chemical inhibition of RNA viruses reveals REDD1 as a host defense factor. Nat Chem Biol 7:712–719
McWhirter SM, Tenoever BR, Maniatis T (2005) Connecting mitochondria and innate immunity. Cell 122:645–647
Melen K, Kinnunen L, Fagerlund R, Ikonen N, Twu KY, Krug RM, Julkunen I (2007) Nuclear and nucleolar targeting of influenza A virus NS1 protein: striking differences between different virus subtypes. J Virol 81:5995–6006
Melville MW, Tan SL, Wambach M, Song J, Morimoto RI, Katze MG (1999) The cellular inhibitor of the PKR protein kinase, P58(IPK), is an influenza virus-activated co-chaperone that modulates heat shock protein 70 activity. J Biol Chem 274:3797–3803
Mibayashi M, Martinez-Sobrido L, Loo YM, Cardenas WB, Gale M Jr, GarcĂa-Sastre A (2007) Inhibition of retinoic acid-inducible gene I-mediated induction of beta interferon by the NS1 protein of influenza A virus. J Virol 81:514–524
Min JY, Krug RM (2006) The primary function of RNA binding by the influenza A virus NS1 protein in infected cells: Inhibiting the 2′-5′ oligo (A) synthetase/RNase L pathway. Proc Natl Acad Sci USA 103:7100–7105
Min JY, Li S, Sen GC, Krug RM (2007) A site on the influenza A virus NS1 protein mediates both inhibition of PKR activation and temporal regulation of viral RNA synthesis. Virology 363:236–243
Mueller SN, Langley WA, Carnero E, GarcĂa-Sastre A, Ahmed R (2010) Immunization with live attenuated influenza viruses that express altered NS1 proteins results in potent and protective memory CD8+ T-cell responses. J Virol 84:1847–1855
Munir M, Berg M (2013) The multiple faces of proteinkinase R in antiviral defense. Virulence 4:85–89
Muraki Y, Furukawa T, Kohno Y, Matsuzaki Y, Takashita E, Sugawara K, Hongo S (2010) Influenza C virus NS1 protein upregulates the splicing of viral mRNAs. J Virol 84:1957–1966
Myong S, Cui S, Cornish PV, Kirchhofer A, Gack MU, Jung JU, Hopfner KP, Ha T (2009) Cytosolic viral sensor RIG-I is a 5′-triphosphate-dependent translocase on double-stranded RNA. Science 323:1070–1074
Nemeroff ME, Barabino SM, Li Y, Keller W, Krug RM (1998) Influenza virus NS1 protein interacts with the cellular 30 kDa subunit of CPSF and inhibits 3′end formation of cellular pre-mRNAs. Mol Cell 1:991–1000
Nemeroff ME, Qian XY, Krug RM (1995) The influenza virus NS1 protein forms multimers in vitro and in vivo. Virology 212:422–428
Noah DL, Twu KY, Krug RM (2003) Cellular antiviral responses against influenza A virus are countered at the posttranscriptional level by the viral NS1A protein via its binding to a cellular protein required for the 3′ end processing of cellular pre-mRNAS. Virology 307:386–395
Obenauer JC, Denson J, Mehta PK, Su X, Mukatira S, Finkelstein DB, Xu X, Wang J, Ma J, Fan Y, Rakestraw KM, Webster RG, Hoffmann E, Krauss S, Zheng J, Zhang Z, Naeve CW (2006) Large-scale sequence analysis of avian influenza isolates. Science 311:1576–1580
O’Neill RE, Talon J, Palese P (1998) The influenza virus NEP (NS2 protein) mediates the nuclear export of viral ribonucleoproteins. EMBO J 17:288–296
Onomoto K, Jogi M, Yoo JS, Narita R, Morimoto S, Takemura A, Sambhara S, Kawaguchi A, Osari S, Nagata K, Matsumiya T, Namiki H, Yoneyama M, Fujita T (2012) Critical role of an antiviral stress granule containing RIG-I and PKR in viral detection and innate immunity. PLoS One 7:e43031
Opitz B, Rejaibi A, Dauber B, Eckhard J, Vinzing M, Schmeck B, Hippenstiel S, Suttorp N, Wolff T (2007) IFNbeta induction by influenza A virus is mediated by RIG-I which is regulated by the viral NS1 protein. Cell Microbiol 9:930–938
Ortigoza MB, Dibben O, Maamary J, Martinez-Gil L, Leyva-Grado VH, Abreu P Jr, Ayllon J, Palese P, Shaw ML (2012) A novel small molecule inhibitor of influenza A viruses that targets polymerase function and indirectly induces interferon. PLoS Pathog 8:e1002668
Oshiumi H, Matsumoto M, Hatakeyama S, Seya T (2009) Riplet/RNF135, a RING finger protein, ubiquitinates RIG-I to promote interferon-beta induction during the early phase of viral infection. J Biol Chem 284:807–817
Oshiumi H, Miyashita M, Matsumoto M, Seya T (2013) A distinct role of Riplet-mediated K63-Linked polyubiquitination of the RIG-I repressor domain in human antiviral innate immune responses. PLoS Pathog 9:e1003533
Pachler K, Vlasak R (2011) Influenza C virus NS1 protein counteracts RIG-I-mediated IFN signalling. Virol J 8:48
Pal S, Rosas JM, Rosas-Acosta G (2010) Identification of the non-structural influenza A viral protein NS1A as a bona fide target of the small ubiquitin-like Modifier by the use of dicistronic expression constructs. J Virol Methods 163:498–504
Palese P (1977) The genes of influenza virus. Cell 10:1–10
Palese P, Zheng H, Engelhardt OG, Pleschka S, GarcĂa-Sastre A (1996) Negative-strand RNA viruses: genetic engineering and applications. Proc Natl Acad Sci USA 93:11354–11358
Park YW, Katze MG (1995) Translational control by influenza virus. Identification of cis-acting sequences and trans-acting factors which may regulate selective viral mRNA translation. J Biol Chem 270:28433–28439
Pica N, Langlois RA, Krammer F, Margine I, Palese P (2012) NS1-truncated live attenuated virus vaccine provides robust protection to aged mice from viral challenge. J Virol 86:10293–10301
Pichlmair A, Reis e Sousa C (2007) Innate recognition of viruses. Immunity 27:370–383
Pichlmair A, Schulz O, Tan CP, Naslund TI, Liljestrom P, Weber F, Reis e Sousa C (2006) RIG-I-mediated antiviral responses to single-stranded RNA bearing 5′-phosphates. Science 314:997–1001
Pichlmair A, Kandasamy K, Alvisi G, Mulhern O, Sacco R, Habjan M, Binder M, Stefanovic A, Eberle CA, Goncalves A, Burckstummer T, Muller AC, Fauster A, Holze C, Lindsten K, Goodbourn S, Kochs G, Weber F, Bartenschlager R, Bowie AG, Bennett KL, Colinge J, Superti-Furga G (2012) Viral immune modulators perturb the human molecular network by common and unique strategies. Nature 487:486–490
Privalsky ML, Penhoet EE (1978) Influenza virus proteins: identity, synthesis, and modification analyzed by two-dimensional gel electrophoresis. Proc Natl Acad Sci USA 75:3625–3629
Privalsky ML, Penhoet EE (1981) The structure and synthesis of influenza virus phosphoproteins. J Biol Chem 256:5368–5376
Qian XY, Alonso-Caplen F, Krug RM (1994) Two functional domains of the influenza virus NS1 protein are required for regulation of nuclear export of mRNA. J Virol 68:2433–2441
Qiu Y, Krug RM (1994) The influenza virus NS1 protein is a poly(A)-binding protein that inhibits nuclear export of mRNAs containing poly(A). J Virol 68:2425–2432
Qiu Y, Nemeroff M, Krug RM (1995) The influenza virus NS1 protein binds to a specific region in human U6 snRNA and inhibits U6-U2 and U6-U4 snRNA interactions during splicing. RNA 1:304–316
Quinlivan M, Zamarin D, GarcĂa-Sastre A, Cullinane A, Chambers T, Palese P (2005) Attenuation of equine influenza viruses through truncations of the NS1 protein. J Virol 79:8431–8439
Rajsbaum R, Albrecht RA, Wang MK, Maharaj NP, Versteeg GA, Nistal-Villan E, GarcĂa-Sastre A, Gack MU (2012) Species-specific inhibition of RIG-I ubiquitination and IFN induction by the influenza A virus NS1 protein. PLoS Pathog 8:e1003059
Richt JA, GarcĂa-Sastre A (2009) Attenuated influenza virus vaccines with modified NS1 proteins. Curr Top Microbiol Immunol 333:177–195
Richt JA, Lekcharoensuk P, Lager KM, Vincent AL, Loiacono CM, Janke BH, Wu WH, Yoon KJ, Webby RJ, Solorzano A, GarcĂa-Sastre A (2006) Vaccination of pigs against swine influenza viruses by using an NS1-truncated modified live-virus vaccine. J Virol 80:11009–11018
Robb NC, Chase G, Bier K, Vreede FT, Shaw PC, Naffakh N, Schwemmle M, Fodor E (2011) The influenza A virus NS1 protein interacts with the nucleoprotein of viral ribonucleoprotein complexes. J Virol 85:5228–5231
Santos A, Pal S, Chacon J, Meraz K, Gonzalez J, Prieto K, Rosas-Acosta G (2013) SUMOylation affects the interferon blocking activity of the influenza A nonstructural protein NS1 without affecting its stability or cellular localization. J Virol 87:5602–5620
Satterly N, Tsai PL, van Deursen J, Nussenzveig DR, Wang Y, Faria PA, Levay A, Levy DE, Fontoura BM (2007) Influenza virus targets the mRNA export machinery and the nuclear pore complex. Proc Natl Acad Sci USA 104:1853–1858
Schmolke M, GarcĂa-Sastre A (2010) Evasion of innate and adaptive immune responses by influenza A virus. Cell Microbiol 12:873–880
Schneider WM, Chevillotte MD, Rice CM (2014) Interferon-stimulated genes: a complex web of host defenses. Annu Rev Immunol 32:513–545
Scholtissek C, von Hoyningen-Huene V (1980) Genetic relatedness of the gene which codes for the nonstructural (NS) protein of different influenza A strains. Virology 102:13–20
Schultz-Cherry S, Dybdahl-Sissoko N, Neumann G, Kawaoka Y, Hinshaw VS (2001) Influenza virus ns1 protein induces apoptosis in cultured cells. J Virol 75:7875–7881
Selman M, Dankar SK, Forbes NE, Jia J-J, Brown EG (2012) Adaptive mutation in influenza A virus non-structural gene is linked to host switching and induces a novel protein by alternative splicing. Emerg Microbes Infect 1:e42
Shapira SD, Gat-Viks I, Shum BO, Dricot A, de Grace MM, Wu L, Gupta PB, Hao T, Silver SJ, Root DE, Hill DE, Regev A, Hacohen N (2009) A physical and regulatory map of host-influenza interactions reveals pathways in H1N1 infection. Cell 139:1255–1267
Shapiro GI, Gurney T Jr, Krug RM (1987) Influenza virus gene expression: control mechanisms at early and late times of infection and nuclear-cytoplasmic transport of virus-specific RNAs. J Virol 61:764–773
Shaw ML, Palese P (2013) Orthomyxoviridae. In: Knipe D.M. HPH (ed) Fields Virology Sixth Edition, vol 1. Wolters Kluwer Health/Lippincott Williams & Wilkins, Philadelphia, pp 1151–1185
Shimizu K, Mullinix MG, Chanock RM, Murphy BR (1982) Temperature-sensitive mutants of influenza A/Udorn/72 (H3N2) virus. I. Isolation of temperature-sensitive mutants some of which exhibit host-dependent temperature sensitivity. Virology 117:38–44
Shin YK, Li Y, Liu Q, Anderson DH, Babiuk LA, Zhou Y (2007a) SH3 binding motif 1 in influenza A virus NS1 protein is essential for PI3K/Akt signaling pathway activation. J Virol 81:12730–12739
Shin YK, Liu Q, Tikoo SK, Babiuk LA, Zhou Y (2007b) Influenza A virus NS1 protein activates the phosphatidylinositol 3-kinase (PI3K)/Akt pathway by direct interaction with the p85 subunit of PI3K. J Gen Virol 88:13–18
Silverman RH (2007) Viral encounters with 2′, 5′-oligoadenylate synthetase and RNase L during the interferon antiviral response. J Virol 81:12720–12729
Skehel JJ (1973) Early polypeptide synthesis in influenza virus-infected cells. Virology 56:394–399
Solorzano A, Webby RJ, Lager KM, Janke BH, GarcĂa-Sastre A, Richt JA (2005) Mutations in the NS1 protein of swine influenza virus impair anti-interferon activity and confer attenuation in pigs. J Virol 79:7535–7543
Soubies SM, Volmer C, Croville G, Loupias J, Peralta B, Costes P, Lacroux C, Guerin JL, Volmer R (2010) Species-specific contribution of the four C-terminal amino acids of influenza A virus NS1 protein to virulence. J Virol 84:6733–6747
Spesock A, Malur M, Hossain MJ, Chen LM, Njaa BL, Davis CT, Lipatov AS, York IA, Krug RM, Donis RO (2011) The virulence of 1997 H5N1 influenza viruses in the mouse model is increased by correcting a defect in their NS1 proteins. J Virol 85:7048–7058
Sridharan H, Zhao C, Krug RM (2010) Species specificity of the NS1 protein of influenza B virus: NS1 binds only human and non-human primate ubiquitin-like ISG15 proteins. J Biol Chem 285:7852–7856
Steel J, Lowen AC, Pena L, Angel M, Solorzano A, Albrecht R, Perez DR, GarcĂa-Sastre A, Palese P (2009) Live attenuated influenza viruses containing NS1 truncations as vaccine candidates against H5N1 highly pathogenic avian influenza. J Virol 83:1742–1753
Steidle S, Martinez-Sobrido L, Mordstein M, Lienenklaus S, GarcĂa-Sastre A, Staheli P, Kochs G (2010) Glycine 184 in nonstructural protein NS1 determines the virulence of influenza A virus strain PR8 without affecting the host interferon response. J Virol 84:12761–12770
Suarez DL, Perdue ML (1998) Multiple alignment comparison of the non-structural genes of influenza A viruses. Virus Res 54:59–69
Takeuchi O, Akira S (2009) Innate immunity to virus infection. Immunol Rev 227:75–86
Talon J, Horvath CM, Polley R, Basler CF, Muster T, Palese P, GarcĂa-Sastre A (2000a) Activation of interferon regulatory factor 3 is inhibited by the influenza A virus NS1 protein. J Virol 74:7989–7996
Talon J, Salvatore M, O’Neill RE, Nakaya Y, Zheng H, Muster T, GarcĂa-Sastre A, Palese P (2000b) Influenza A and B viruses expressing altered NS1 proteins: a vaccine approach. Proc Natl Acad Sci USA 97:4309–4314
Tang Y, Zhong G, Zhu L, Liu X, Shan Y, Feng H, Bu Z, Chen H, Wang C (2010) Herc5 attenuates influenza A virus by catalyzing ISGylation of viral NS1 protein. J Immunol 184:5777–5790
Treanor JJ, Snyder MH, London WT, Murphy BR (1989) The B allele of the NS gene of avian influenza viruses, but not the A allele, attenuates a human influenza A virus for squirrel monkeys. Virology 171:1–9
Twu KY, Kuo RL, Marklund J, Krug RM (2007) The H5N1 influenza virus NS genes selected after 1998 enhance virus replication in mammalian cells. J Virol 81:8112–8121
Twu KY, Noah DL, Rao P, Kuo RL, Krug RM (2006) The CPSF30 binding site on the NS1A protein of influenza A virus is a potential antiviral target. J Virol 80:3957–3965
Vanhaesebroeck B, Guillermet-Guibert J, Graupera M, Bilanges B (2010) The emerging mechanisms of isoform-specific PI3K signalling. Nat Rev Mol Cell Biol 11:329–341
Varble A, Chua MA, Perez JT, Manicassamy B, Garcia-Sastre A, tenOever BR (2010) Engineered RNA viral synthesis of microRNAs. Proc Natl Acad Sci USA 107:11519–11524
Varga ZT, Ramos I, Hai R, Schmolke M, GarcĂa-Sastre A, Fernandez-Sesma A, Palese P (2011) The influenza virus protein PB1-F2 inhibits the induction of type I interferon at the level of the MAVS adaptor protein. PLoS Pathog 7:e1002067
Versteeg GA, Hale BG, van Boheemen S, Wolff T, Lenschow DJ, GarcĂa-Sastre A (2010) Species-specific antagonism of host ISGylation by the influenza B virus NS1 protein. J Virol 84:5423–5430
Vincent AL, Ma W, Lager KM, Janke BH, Webby RJ, GarcĂa-Sastre A, Richt JA (2007) Efficacy of intranasal administration of a truncated NS1 modified live influenza virus vaccine in swine. Vaccine 25:7999–8009
Wacheck V, Egorov A, Groiss F, Pfeiffer A, Fuereder T, Hoeflmayer D, Kundi M, Popow-Kraupp T, Redlberger-Fritz M, Mueller CA, Cinatl J, Michaelis M, Geiler J, Bergmann M, Romanova J, Roethl E, Morokutti A, Wolschek M, Ferko B, Seipelt J, Dick-Gudenus R, Muster T (2010) A novel type of influenza vaccine: safety and immunogenicity of replication-deficient influenza virus created by deletion of the interferon antagonist NS1. J Infect Dis 201:354–362
Wahle E, Keller W (1996) The biochemistry of polyadenylation. Trends Biochem Sci 21:247–250
Walkiewicz MP, Basu D, Jablonski JJ, Geysen HM, Engel DA (2011) Novel inhibitor of influenza non-structural protein 1 blocks multi-cycle replication in an RNase L-dependent manner. J Gen Virol 92:60–70
Wang L, Suarez DL, Pantin-Jackwood M, Mibayashi M, GarcĂa-Sastre A, Saif YM, Lee CW (2008) Characterization of influenza virus variants with different sizes of the non-structural (NS) genes and their potential as a live influenza vaccine in poultry. Vaccine 26:3580–3586
Wang W, Krug RM (1996) The RNA-binding and effector domains of the viral NS1 protein are conserved to different extents among influenza A and B viruses. Virology 223:41–50
Wang W, Riedel K, Lynch P, Chien CY, Montelione GT, Krug RM (1999) RNA binding by the novel helical domain of the influenza virus NS1 protein requires its dimer structure and a small number of specific basic amino acids. RNA 5:195–205
Wang X, Basler CF, Williams BR, Silverman RH, Palese P, GarcĂa-Sastre A (2002) Functional replacement of the carboxy-terminal two-thirds of the influenza A virus NS1 protein with short heterologous dimerization domains. J Virol 76:12951–12962
Wang X, Li M, Zheng H, Muster T, Palese P, Beg AA, GarcĂa-Sastre A (2000) Influenza A virus NS1 protein prevents activation of NF-kappaB and induction of alpha/beta interferon. J Virol 74:11566–11573
Weber F, Kochs G, Haller O (2004) Inverse interference: how viruses fight the interferon system. Viral Immunol 17:498–515
Williams BR (2001) Signal integration via PKR. Sci STKE 89:re2
Wolstenholme AJ, Barrett T, Nichol ST, Mahy BW (1980) Influenza virus-specific RNA and protein syntheses in cells infected with temperature-sensitive mutants defective in the genome segment encoding nonstructural proteins. J Virol 35:1–7
Xu K, Klenk C, Liu B, Keiner B, Cheng J, Zheng BJ, Li L, Han Q, Wang C, Li T, Chen Z, Shu Y, Liu J, Klenk HD, Sun B (2011) Modification of nonstructural protein 1 of influenza A virus by SUMO1. J Virol 85:1086–1098
Yoneyama M, Kikuchi M, Natsukawa T, Shinobu N, Imaizumi T, Miyagishi M, Taira K, Akira S, Fujita T (2004) The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses. Nat Immunol 5:730–737
Yuan W, Krug RM (2001) Influenza B virus NS1 protein inhibits conjugation of the interferon (IFN)-induced ubiquitin-like ISG15 protein. EMBO J 20:362–371
Zeng W, Sun L, Jiang X, Chen X, Hou F, Adhikari A, Xu M, Chen ZJ (2010) Reconstitution of the RIG-I pathway reveals a signaling role of unanchored polyubiquitin chains in innate immunity. Cell 141:315–330
Zielecki F, Semmler I, Kalthoff D, Voss D, Mauel S, Gruber AD, Beer M, Wolff T (2010) Virulence determinants of avian H5N1 influenza A virus in mammalian and avian hosts: role of the C-terminal ESEV motif in the viral NS1 protein. J Virol 84:10708–10718
Zhao C, Collins MN, Hsiang TY, Krug RM (2013) Interferon-induced ISG15 pathway: an ongoing virus-host battle. Trends Microbiol 21:181–186
Zhao C, Hsiang TY, Kuo RL, Krug RM (2011) ISG15 conjugation system targets the viral NS1 protein in influenza A virus-infected cells. Proc Natl Acad Sci USA 107:2253–2258
Zhirnov OP, Klenk HD (2007) Control of apoptosis in influenza virus-infected cells by up-regulation of Akt and p53 signaling. Apoptosis 12:1419–1432
Zhirnov OP, Konakova TE, Wolff T, Klenk HD (2002) NS1 protein of influenza A virus down-regulates apoptosis. J Virol 76:1617–1625
Zhou B, Li Y, Belser JA, Pearce MB, Schmolke M, Subba AX, Shi Z, Zaki SR, Blau DM, GarcĂa-Sastre A, Tumpey TM, Wentworth DE (2010) NS-based live attenuated H1N1 pandemic vaccines protect mice and ferrets. Vaccine 28:8015–8025
Acknowledgments
Work in AG-S laboratory is partially funded by NIH grants U19AI106754, U19AI083025, P01AI090935, P01AI097092, U19AI089987, R01AI088770, R01AI079110, R01AI089539, U01AI095611, R01DA033773; NIH contracts HHSN272201000054C, HHSN272200900032C, HHSN272201300023C; and by CRIP (Center for Research on Influenza Pathogenesis), and NIAID funded Center of Excellence in Influenza Research and Surveillance (CEIRS, contract # HHSN272201400008C).
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Ayllon, J., GarcĂa-Sastre, A. (2014). The NS1 Protein: A Multitasking Virulence Factor. In: Oldstone, M., Compans, R. (eds) Influenza Pathogenesis and Control - Volume II. Current Topics in Microbiology and Immunology, vol 386. Springer, Cham. https://doi.org/10.1007/82_2014_400
Download citation
DOI: https://doi.org/10.1007/82_2014_400
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-11157-5
Online ISBN: 978-3-319-11158-2
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)